What baclofen dose and titration schedule should be used in an adult with persistent or intractable hiccups, and how should dosing be adjusted for impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Baclofen Dosing for Hiccups

For persistent or intractable hiccups in adults with normal renal function, start baclofen at 5 mg three times daily and titrate gradually up to a maximum of 20 mg three times daily (60 mg/day total), though most patients respond to lower doses of 15–30 mg/day. 1

Initial Dosing Strategy

  • Start with 5 mg three times daily in adults with normal renal function 2, 1
  • If no response after 3–5 days, increase to 10 mg three times daily 1
  • Maximum effective dose is typically 20 mg three times daily (60 mg/day), though most patients respond to lower doses 1
  • Older adults rarely tolerate doses greater than 30–40 mg per day due to increased risk of muscle weakness, urinary dysfunction, cognitive effects, and sedation 2

Evidence Base

  • Baclofen is supported by small randomized, placebo-controlled trials and is recommended as first-line therapy alongside gabapentin for persistent and intractable hiccups 1
  • A systematic review identified baclofen as one of only two agents (along with metoclopramide) studied in randomized controlled trials for hiccups 3
  • Baclofen is less likely than neuroleptic agents (e.g., chlorpromazine, haloperidol) to cause side effects during long-term therapy 1

Critical Renal Dosing Adjustments

In patients with any degree of renal impairment, baclofen poses extreme neurotoxicity risk and requires dramatic dose reduction or complete avoidance:

  • End-stage renal disease (ESRD)/dialysis patients: Even the "recommended" 5 mg/day dose has caused severe encephalopathy in hemodialysis patients 4, 5
  • Single 25 mg dose caused profound altered mental status and unconsciousness in an ESRD patient, requiring two extra hemodialysis sessions for recovery 6
  • Avoid baclofen entirely if chronic kidney disease is present; seek alternative agents such as gabapentin (with appropriate renal dosing) or metoclopramide 6
  • If baclofen must be used in mild-to-moderate renal impairment, start at 2.5 mg once or twice daily maximum, monitor closely for sedation, confusion, and muscle weakness, and check renal function within 3–7 days 2

Monitoring and Safety

  • Monitor for muscle weakness, urinary retention, cognitive impairment, and sedation at every dose adjustment 2
  • Never discontinue abruptly—taper gradually to avoid central nervous system irritability, seizures, and withdrawal symptoms 2
  • Assess fall risk in older adults and those with ataxia or altered mental status 7
  • Recheck renal function regularly during therapy, as even mild impairment dramatically increases toxicity risk 4, 6, 5

Common Pitfalls

  • Using standard 5 mg TID dosing in dialysis or ESRD patients is dangerous—multiple case reports document severe encephalopathy even at this "low" dose 4, 5
  • Failing to recognize that baclofen is renally excreted and accumulates rapidly in kidney disease 6
  • Combining baclofen with other CNS depressants (benzodiazepines, opioids) without dose reduction increases sedation and respiratory depression risk 2
  • Stopping baclofen suddenly after chronic use can precipitate withdrawal seizures 2

Alternative Agents in Renal Impairment

  • Gabapentin is an alternative first-line agent but also requires renal dose adjustment and carries risk of sedation and accumulation in kidney disease 7, 1
  • Metoclopramide (10 mg three times daily) is supported by randomized trial data and may be safer in renal impairment, though it carries risk of extrapyramidal side effects with prolonged use 3, 1
  • Chlorpromazine (25–50 mg three to four times daily) is the only FDA-approved agent for hiccups but has higher side effect burden, particularly orthostasis and sedation 3, 1

References

Research

Systemic review: the pathogenesis and pharmacological treatment of hiccups.

Alimentary pharmacology & therapeutics, 2015

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Baclofen-associated encephalopathy in a hemodialysis patient with hiccups].

Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2006

Guideline

Gabapentin Use in Patients with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.